China urged to abandon plan to sell unproven cell therapies
An international stem-cell body says the country’s proposed law could put patients at risk. An international group of stem-cell researchers is urging China to cancel draft regulations that would permit some hospitals to sell therapies developed from patients’ own cells, without approval from the nation’s drug regulator. The International Society for Stem Cell Research (ISSCR) sent a